Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM )


Journal article


A. Deistung, F. Schweser, S. Heiland, M. Bendszus, W. Wick, J. Reichenbach, A. Radbruch
2011

Semantic Scholar
Cite

Cite

APA
Deistung, A., Schweser, F., Heiland, S., Bendszus, M., Wick, W., Reichenbach, J., & Radbruch, A. (2011). Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with newly diagnosed Glioblastoma using Quantitative Susceptibility Mapping ( QSM ).

Chicago/Turabian
Deistung, A., F. Schweser, S. Heiland, M. Bendszus, W. Wick, J. Reichenbach, and A. Radbruch. “Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with Newly Diagnosed Glioblastoma Using Quantitative Susceptibility Mapping ( QSM )” (2011).

MLA
Deistung, A., et al. Assessment of Intratumoral Susceptibility Signals ( ITSS ) in Patients with Newly Diagnosed Glioblastoma Using Quantitative Susceptibility Mapping ( QSM ). 2011.


Abstract

Susceptibility Mapping (QSM) Andreas Deistung, Ferdinand Schweser, Sabine Heiland, Martin Bendszus, Wolfgang Wick, Jürgen Rainer Reichenbach, and Alexander Radbruch Medical Physics Group, Department of Diagnostic and Interventional Radiology I, Jena University Hospital, Jena, Germany, Department of Neuroradiology, University of Heidelberg Medical Center, Heidelberg, Germany, Department of Neurooncology, University of Heidelberg Medical Center, Heidelberg, Germany